Literature DB >> 33273983

Clinical efficacy of duodenoscopy combined with laparoscopy in the treatment of patients with severe acute pancreatitis and pancreatic pseudocyst, and the effects on IL-6 and CRP.

Lianhua Zheng1, Shasha Huang2, Fengji Liu3, Juan Yang3.   

Abstract

The study aimed to investigate the clinical efficacy of duodenoscopy combined with laparoscopy in the treatment of patients with severe acute pancreatitis (SAP) and pancreatic pseudocyst (PP), and its effects on serum inflammatory factors. Altogether 94 patients complicated with SAP and PP who were admitted to Weifang People's Hospital (Weifang, China) from September 2015 to December 2018 were included. Based on the different operation methods, 49 patients who underwent traditional laparotomy under laparoscopic surgery were included in group A, and 45 patients who underwent duodenoscopy and laparoscopy under duodenoscope to treat the drainage of nipple and pancreatic pseudocysts were included in group B. The expression levels of related serum indexes and serum stress indexes before and at 48 h after surgery, the postoperative nausea, vomiting and abdominal pain scores, as well as the clinical efficacy, perioperative related indexes, recovery and complications were compared between the two groups. The prognostic factors in both groups were assessed via Logistic univariate and multivariate analyses. C-reactive protein (CRP), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin-β (IL-β), endotoxin and nuclear factor κB (NF-κB) were significantly lower in group B than those in group A (P<0.001). Upregulating cortisol and norepinephrine in group B was lower than that in group A (P<0.001). The total effective rate in group B was higher than that in group A (P<0.05). The perioperative related indexes, recovery, and postoperative complications in group B were better than those in group A (P<0.05). Scores of abdominal pain, nausea and vomiting in group B were markedly lower than those in group A (P<0.001). Multivariate Logistic regression analysis showed that CRP, TNF-α, IL-6, IL-β and surgical methods were independent risk factors for the prognosis of patients with SAP and PP. In conclusion, the combined treatment with duodenoscopy and laparoscopic surgery has little inflammatory and stress reaction, and it is highly safe, worthy to be popularized.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  CRP; IL-6; TNF-α; duodenoscopy; laparoscopy; severe acute pancreatitis complicated with pancreatic pseudocyst

Year:  2020        PMID: 33273983      PMCID: PMC7706390          DOI: 10.3892/etm.2020.9487

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  21 in total

1.  Systematic review comparing endoscopic, percutaneous and surgical pancreatic pseudocyst drainage.

Authors:  Anthony Yuen Bun Teoh; Vinay Dhir; Zhen-Dong Jin; Mitsuhiro Kida; Dong Wan Seo; Khek Yu Ho
Journal:  World J Gastrointest Endosc       Date:  2016-03-25

Review 2.  Surgical Management of Pancreatic Pseudocysts.

Authors:  Lea Matsuoka; Sophoclis P Alexopoulos
Journal:  Gastrointest Endosc Clin N Am       Date:  2018-01-05

3.  The effect of smoking on expression of IL-6 and antioxidants in pancreatic fluids and tissues in patients with chronic pancreatitis.

Authors:  Mariola Sliwińska-Mossoń; Halina Milnerowicz; Monika Jabłonowska; Stanisław Milnerowicz; Stanisław Nabzdyk; Jerzy Rabczyński
Journal:  Pancreatology       Date:  2012-05-05       Impact factor: 3.996

4.  Outcome of Acute Pancreatic and Peripancreatic Collections Occurring in Patients With Acute Pancreatitis.

Authors:  Manish Manrai; Rakesh Kochhar; Vikas Gupta; Thakur Deen Yadav; Narendra Dhaka; Naveen Kalra; Saroj K Sinha; Niranjan Khandelwal
Journal:  Ann Surg       Date:  2018-02       Impact factor: 12.969

5.  MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients.

Authors:  Ulises De la Cruz-Mosso; Trinidad García-Iglesias; Richard Bucala; Iris Estrada-García; Laura González-López; Sergio Cerpa-Cruz; Isela Parra-Rojas; Jorge Iván Gámez-Nava; Edsaúl Emilio Pérez-Guerrero; José Francisco Muñoz-Valle
Journal:  Cell Immunol       Date:  2017-12-26       Impact factor: 4.868

6.  Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.

Authors:  Geltrude Mingrone; Simona Panunzi; Andrea De Gaetano; Caterina Guidone; Amerigo Iaconelli; Giuseppe Nanni; Marco Castagneto; Stefan Bornstein; Francesco Rubino
Journal:  Lancet       Date:  2015-09-05       Impact factor: 79.321

7.  Tanshinone IIA Attenuates Chronic Pancreatitis-Induced Pain in Rats via Downregulation of HMGB1 and TRL4 Expression in the Spinal Cord.

Authors:  Ye-song Wang; Yuan-yuan Li; Li-hua Wang; Ying Kang; Jie Zhang; Zi-quan Liu; Kun Wang; Alan David Kaye; Lei Chen
Journal:  Pain Physician       Date:  2015 Jul-Aug       Impact factor: 4.965

8.  Thoracic Epidural Analgesia and Mortality in Acute Pancreatitis: A Multicenter Propensity Analysis.

Authors:  Matthieu Jabaudon; Nouria Belhadj-Tahar; Thomas Rimmelé; Olivier Joannes-Boyau; Stéphanie Bulyez; Jean-Yves Lefrant; Yannick Malledant; Marc Leone; Paer-Selim Abback; Fabienne Tamion; Hervé Dupont; Brice Lortat-Jacob; Philippe Guerci; Thomas Kerforne; Raphael Cinotti; Laurent Jacob; Philippe Verdier; Thierry Dugernier; Bruno Pereira; Jean-Michel Constantin
Journal:  Crit Care Med       Date:  2018-03       Impact factor: 7.598

9.  Risk Factors for Worsening of Acute Pancreatitis in Patients Admitted with Mild Acute Pancreatitis.

Authors:  Zhouxiang Jin; Lubai Xu; Xiangyu Wang; Dinghua Yang
Journal:  Med Sci Monit       Date:  2017-02-26

10.  Development and validation of a risk prediction score for severe acute pancreatitis.

Authors:  Wandong Hong; Keith D Lillemoe; Shuang Pan; Vincent Zimmer; Evangelos Kontopantelis; Simon Stock; Maddalena Zippi; Chao Wang; Mengtao Zhou
Journal:  J Transl Med       Date:  2019-05-08       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.